Ads
related to: acute myeloid leukemia news- Treatment Option
Visit The Physician Website To
Learn More About This Treatment.
- Mechanism Of Action
Learn How To Treat Patients
With Ph+ CML-CP Today.
- Efficacy Information
Physicians, See How This Treatment
May Help Your Patients Today.
- Safety Profile
Physicians, See Important Safety
Information About This Treatment.
- Unmet Needs In CML
Are Your Patients Experiencing
Intolerance? Learn About Treatment.
- View Patient Profiles
Patients Experience Treatment
Intolerance & Suboptimal Responses
- Treatment Option
Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates PR Newswire SUZHOU, China and ROCKVILLE, Md., May 23, 2024 SUZHOU, China and ROCKVILLE, Md., May 23, 2024 /PRNewswire/ -- Ascentage Pharma
Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $27.94
ETF DAILY NEWS· 6 days agoKura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports.
MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the stock. A number of other research ...
Aileron Therapeutics (NASDAQ:ALRN) Announces Earnings Results, Misses Estimates By $0.72 EPS
ETF DAILY NEWS· 5 days agoAileron Therapeutics (NASDAQ:ALRN – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.86) EPS for the quarter, missing the consensus estimate of ($0.14 ...
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Receives $25.60 Consensus Target Price from...
ETF DAILY NEWS· 4 days agoShares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are presently covering the firm, MarketBeat ...
Incyte (NASDAQ:INCY) Coverage Initiated at Deutsche Bank Aktiengesellschaft
ETF DAILY NEWS· 2 days agoEquities research analysts at Deutsche Bank Aktiengesellschaft began coverage on shares of Incyte (NASDAQ:INCY – Get Free Report) in a research note issued to investors on Thursday, MarketBeat ...